718 related articles for article (PubMed ID: 33211535)
1. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.
Kesselheim AS; Darrow JJ; Kulldorff M; Brown BL; Mitra-Majumdar M; Lee CC; Moneer O; Avorn J
Health Aff (Millwood); 2021 Jan; 40(1):25-32. PubMed ID: 33211535
[TBL] [Abstract][Full Text] [Related]
2. Vaccine safety - is the SARS-CoV-2 vaccine any different?
Tau N; Yahav D; Shepshelovich D
Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
[TBL] [Abstract][Full Text] [Related]
3. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
[TBL] [Abstract][Full Text] [Related]
4. The Advisory Committee on Immunization Practices' Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.
McClung N; Chamberland M; Kinlaw K; Bowen Matthew D; Wallace M; Bell BP; Lee GM; Talbot HK; Romero JR; Oliver SE; Dooling K
MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(47):1782-1786. PubMed ID: 33237895
[TBL] [Abstract][Full Text] [Related]
5. FDA authorizes first single-shot COVID-19 vaccine.
Mullard A
Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753
[No Abstract] [Full Text] [Related]
6. FDA Approval and Regulation of Pharmaceuticals, 1983-2018.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2020 Jan; 323(2):164-176. PubMed ID: 31935033
[TBL] [Abstract][Full Text] [Related]
7. Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study.
Wallach JD; Ciani O; Pease AM; Gonsalves GS; Krumholz HM; Taylor RS; Ross JS
BMC Med; 2018 Mar; 16(1):45. PubMed ID: 29562926
[TBL] [Abstract][Full Text] [Related]
8. Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy.
Parums DV
Med Sci Monit; 2021 Sep; 27():e934625. PubMed ID: 34483336
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
[TBL] [Abstract][Full Text] [Related]
10. The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements.
Wallach JD; Ross JS; Naci H
Clin Trials; 2018 Jun; 15(3):219-229. PubMed ID: 29871509
[TBL] [Abstract][Full Text] [Related]
11. Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
Slaoui M; Hepburn M
N Engl J Med; 2020 Oct; 383(18):1701-1703. PubMed ID: 32846056
[No Abstract] [Full Text] [Related]
12. Update From the Advisory Committee on Immunization Practices.
O Leary ST; Maldonado YA; Kimberlin DW
J Pediatric Infect Dis Soc; 2020 Dec; 9(6):645-649. PubMed ID: 33180938
[TBL] [Abstract][Full Text] [Related]
13. Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines.
Moro PL; McNeil MM
Expert Rev Vaccines; 2022 Mar; 21(3):281-284. PubMed ID: 34957900
[No Abstract] [Full Text] [Related]
14. COVID-19 vaccines: rapid development, implications, challenges and future prospects.
Kashte S; Gulbake A; El-Amin Iii SF; Gupta A
Hum Cell; 2021 May; 34(3):711-733. PubMed ID: 33677814
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.
CDC COVID-19 Vaccine Breakthrough Case Investigations Team
MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):792-793. PubMed ID: 34043615
[TBL] [Abstract][Full Text] [Related]
16. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
Dal-Ré R
Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602
[No Abstract] [Full Text] [Related]
17. Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
Rizk JG; Forthal DN; Kalantar-Zadeh K; Mehra MR; Lavie CJ; Rizk Y; Pfeiffer JP; Lewin JC
Drug Discov Today; 2021 Feb; 26(2):593-603. PubMed ID: 33253920
[TBL] [Abstract][Full Text] [Related]
18. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1922-1924. PubMed ID: 33332292
[TBL] [Abstract][Full Text] [Related]
19. The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.
Dooling K; McClung N; Chamberland M; Marin M; Wallace M; Bell BP; Lee GM; Talbot HK; Romero JR; Oliver SE
MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(49):1857-1859. PubMed ID: 33301429
[TBL] [Abstract][Full Text] [Related]
20. Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
MacPherson A; Hutchinson N; Schneider O; Oliviero E; Feldhake E; Ouimet C; Sheng J; Awan F; Wang C; Papenburg J; Basta NE; Kimmelman J
Ann Intern Med; 2021 Mar; 174(3):326-334. PubMed ID: 33226855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
